Neoplasms: all 9,610 studies
Page 87 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- Phase I AZD2281/Cisplatin in Advanced Solid Tumour PatientsCompletedNCT00782574Phase 1
- Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard TherapyCompletedNCT00782002Phase 1
- Infusional C-myb ASODN in Advanced Hematologic MalignanciesCompletedNCT00780052Phase 1
- Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating TanespimycinCompletedNCT00779428Phase 2
- A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid TumourCompletedNCT00778128Phase 1
- Study of Single Agent Perifosine for Recurrent Pediatric Solid TumorsCompletedNCT00776867Phase 1
- Reactions to Disease Risk InformationCompletedNCT00774254Not applicable
- A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory MalignanciesCompletedNCT00772876Phase 1
- Neuropsychological and Behavioral Testing in Younger Patients With CancerCompletedNCT00772200
- An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer PainCompletedNCT00771199Phase 4
- AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRCompletedNCT00770536Phase 1
- Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem CellsCompletedNCT00770523
- Perceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWithdrawnNCT00770419
- Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is AvailableCompletedNCT00768391Phase 1
- Permission to Collect Blood Over Time for ResearchTerminatedNCT00767234
- Spectroscopic Evaluation of Cervical NeoplasiaCompletedNCT00766701
- Health Economic Evaluation of Primovist-enhanced Liver MRICompletedNCT00764621Phase 4
- A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor MalignanciesCompletedNCT00761696Phase 1
- Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)Status unknownNCT00751894Phase 2
- Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursCompletedNCT00750425Phase 1
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
- An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate CancerCompletedNCT00748358Phase 2
- Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain TumorsCompletedNCT00747253Phase 1
- A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid TumorsCompletedNCT00744562Phase 1
- A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid TumorsCompletedNCT00743067Phase 1
- A Bioavailability Study of GSK1363089 in Subjects With Solid TumorsCompletedNCT00742261Phase 1
- A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid TumorsCompletedNCT00742131Phase 1
- Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in JapanTerminatedNCT00742105Phase 1
- A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesCompletedNCT00741403Phase 1
- A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With AzacitidineCompletedNCT00741234Phase 1
- Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid TumorsCompletedNCT00739414Phase 1
- A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory TumoursCompletedNCT00737555Phase 1
- Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)Active, not recruitingNCT00737399Early Phase 1
- A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic CancerCompletedNCT00736372Phase 1
- Management of Cervical Intraepithelial Neoplasia Grade 2CompletedNCT00733109Phase 4
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TerminatedNCT00733031Phase 1
- Open-label Study of Topotecan and Pazopanib in Advanced Solid TumorsCompletedNCT00732420Phase 1
- A Study of Tor Kinase Inhibitor in Advanced TumorsCompletedNCT00731263Phase 1
- Phase I Study of U3P1287/01, Including Patients With Advanced Solid TumorsCompletedNCT00730470Phase 1
- The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their PrognosisStatus unknownNCT00728871Not applicable
- A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid TumorsCompletedNCT00728793Phase 1
- Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell TransplantWithdrawnNCT00728585Phase 2
- Protective Effect of Mangafodipir Against Oxaliplatin NeurotoxicityCompletedNCT00727922Phase 2
- Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsTerminatedNCT00726687Phase 1
- Tetrodotoxin Open-label Efficacy and Safety Continuation StudyCompletedNCT00726011Phase 3
- Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of MalignancyCompletedNCT00725387
- A Phase 1 Dose Escalation Study of IPI-493TerminatedNCT00724425Phase 1
- A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid TumorsCompletedNCT00721669Phase 1
- AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid TumorCompletedNCT00719524Phase 1
- A Phase 1 Study of ABT-869 in Subjects With Solid TumorsCompletedNCT00718380Phase 1
- Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer PatientsWithdrawnNCT00718055
- Solid Tumors Using Ixabepilone and DasatinibCompletedNCT00717704Phase 1
- Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantCompletedNCT00716911Not applicable
- Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)CompletedNCT00714701
- Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00714181Phase 1
- Lymphadenectomy In Ovarian NeoplasmsCompletedNCT00712218Not applicable
- A Study of ARRY-334543 and Capecitabine in Patients With Advanced CancerCompletedNCT00710736Phase 1
- Safety Study of GPX-150 in Patients With Solid TumorsCompletedNCT00710125Phase 1
- Outcomes of Triaged Family Care in Advanced CancerCompletedNCT00709176Not applicable
- Study of Rapamycin Plus Ketoconazole in Advanced CancersCompletedNCT00708591Phase 1
- Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.CompletedNCT00708513
- A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid TumorsCompletedNCT00708006Phase 1
- Rapamycin in Advanced CancersCompletedNCT00707135Phase 1
- The Accuracy of CHOLINE PET CT in the Diagnosis of Urological MalignanciesStatus unknownNCT00706212
- Radiofrequency Ablation of TumorsCompletedNCT00705497Phase 1
- PTC299 for Treatment of Advanced CancerTerminatedNCT00704821Phase 1
- A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)CompletedNCT00704054Phase 1
- Phase I Study of Docetaxel and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703625Phase 1
- Phase I Study of DOXIL and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703170Phase 1
- Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid TumoursCompletedNCT00702494Phase 1
- Video/Audio Distraction Analgesia for Simulated Oncology Procedure PainCompletedNCT00701571Not applicable
- Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursCompletedNCT00697879Phase 1
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
- Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced MalignanciesCompletedNCT00697632Phase 1
- Study of Capecitabine In Patients With Solid TumorsCompletedNCT00697502Phase 1
- Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or LymphomaTerminatedNCT00695448Phase 1
- Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical TrialsCompletedNCT00695422
- Evaluation of Pegfilgrastim for Stem Cell Mobilization in ChildrenTerminatedNCT00695370Phase 2
- Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)CompletedNCT00693927Phase 2
- Safety Study to Evaluate CHR-2797 in Patients With Advanced TumoursCompletedNCT00692354Phase 1
- Safety Study of CALAA-01 to Treat Solid Tumor CancersTerminatedNCT00689065Phase 1
- Study of STA-9090, Administered Twice-Weekly in Patients With Solid TumorsStatus unknownNCT00688116Phase 1
- Study of STA-9090, Administered Once-Weekly in Patients With Solid TumorsCompletedNCT00687934Phase 1
- 11C-Acetate PET/CT Non-FDG-Avid TumorsStatus unknownNCT00687778
- Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or LymphomaCompletedNCT00687622Phase 1
- Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) PersistenceTerminatedNCT00682552Not applicable
- A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid TumorsWithdrawnNCT00682279Phase 1
- Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced MalignanciesCompletedNCT00679133Phase 1
- Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00678769Phase 1
- AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor CancersCompletedNCT00678132Phase 1
- Impact of Microparticles on Postoperative Complications in Surgical PatientsCompletedNCT00677781
- Study of MLN4924 in Adult Patients With Nonhematologic MalignanciesCompletedNCT00677170Phase 1
- A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.CompletedNCT00677001Phase 1
- A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.CompletedNCT00676910Phase 1
- A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.CompletedNCT00676299Phase 1
- Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic MalignanciesCompletedNCT00675831Phase 1
- Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic TumorsCompletedNCT00675350Phase 1
- A Phase I Study of BIIB015 in Relapsed/Refractory Solid TumorsCompletedNCT00674947Phase 1
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following TransplantationTerminatedNCT00672152Phase 1
- A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNCT00672009Phase 2